Lipid Peroxidation Products Formation with Various Intravenous Iron Preparations in Chronic Kidney Disease

By Ganguli Anirban   Kohli Harbir Singh   Khullar Madhu   Lal Gupta Krishan   Jha Vivekanand   Sakhuja Vinay  

Renal Failure, Vol. 31, Iss. 2, 2009-02 ,pp. : 106-110

Informa Healthcare

Access to resources Recommend Favorite

Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin

By Post James   Wilkes Barry   Michelis Michael  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 719-723

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy

By Fukagawa Masafumi   Kasuga Hirotake   Joseph Devanand   Sawata Hiroshi   Junge Guido   Moore Alan   Akiba Takashi  

Clinical and Experimental Nephrology, Vol. 18, Iss. 1, 2014-02 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

Role of lean body mass for estimation of glomerular filtration rate in patients with chronic kidney disease with various body mass indices

By Ozmen Sehmus   Kaplan Mehmet Ali   Kaya Halil   Akin Davut   Danis Ramazan   Kizilkan Berfin   Yazanel Orhan  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 2, 2009-03 ,pp. : 171-176

Informa Healthcare

Access to resources Recommend Favorite

Care of elderly patients with chronic kidney disease

By Arora Pradeep   Mustafa Reem   Karam Jyotheen   Khalil Patricia   Wilding Greg   Ranjan Rajiv   Lohr James  

International Urology and Nephrology, Vol. 38, Iss. 2, 2006-06 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite